| 10745364 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, Brian M. Andresen, Kenneth J. Barr +9 more |
2020-08-18 |
$154,425,000 |
| 10221142 |
Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, Nunzio Sciammetta +5 more |
2019-03-05 |
$69,271,000 |
| 10221146 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, Brian M. Andresen, Kenneth J. Barr +9 more |
2019-03-05 |
$69,271,000 |
| 10196354 |
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof |
Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more |
2019-02-05 |
$410,559,000 |
| 9969749 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio +9 more |
2018-05-15 |
$97,235,000 |
| 9943516 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-04-17 |
$82,364,000 |
| 9932350 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-04-03 |
$81,854,000 |
| 9926330 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-03-27 |
$54,851,000 |
| 9844553 |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more |
2017-12-19 |
$150,910,000 |
| 9809561 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, Brian M. Andresen, Kenneth J. Barr +9 more |
2017-11-07 |
$37,151,000 |
| 9783511 |
Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more |
2017-10-10 |
$124,275,000 |
| 9745265 |
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof |
Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more |
2017-08-29 |
$63,155,000 |
| 9663502 |
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more |
2017-05-30 |
$63,958,000 |
| 9663522 |
3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof |
Kenneth J. Barr, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony, Matthew H. Daniels +2 more |
2017-05-30 |
$63,958,000 |
| 9567333 |
Triazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more |
2017-02-14 |
$97,202,000 |
| 9556168 |
N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof |
Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more |
2017-01-31 |
$47,481,000 |
| 9518055 |
Imidazopyridyl compounds as aldosterone synthase inhibitors |
Amjad Ali, D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke +8 more |
2016-12-13 |
$109,867,000 |
| 9487490 |
3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof |
Kenneth J. Barr, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang, Brian M. Andresen +3 more |
2016-11-08 |
$82,214,000 |
| 9382226 |
Aldosterone synthase inhibitors |
Scott B. Hoyt, Min K. Park, Clare London, Yusheng Xiong, D. Jonathan Bennett +7 more |
2016-07-05 |
$61,670,000 |
| 9351973 |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more |
2016-05-31 |
$68,752,000 |
| 9193724 |
Triazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more |
2015-11-24 |
$115,122,000 |